Free Newsletter
FEATURES >> The most interesting logos in Pharma
CDC vaccine advisers have financial conflicts, IG says
The conflicts-of-interest police have turned their attention to the Centers for Disease Control and Prevention. The inspector general of the Department of Health and Human Services issued a report saying that CDC did a poor job of screening its medical experts for financial conflicts when it engaged them for advice on vaccine safety, the New York Times reports.
According to the report, 64 percent of the advisers had potential conflicts of interest their were either never identified of never resolved, and 13 percent of them had never filed the required conflicts disclosures--an omission that should have kept them from serving at all. Three percent even voted on issues that the agency's ethics officers had barred them from considering, the Times says.
CDC responded to the report by saying that it already has strengthened its conflicts of interest process since the time period covered in the IG's review. The IG's report is expected to be released later today.
- read the NYT piece
Related Articles:
Pharma, academia ties difficult to unwind
Journals plot new conflicts-of-interest rules
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities



SHARE
WITH: